Solactive Future Pharmaceutical Europe Index
The Solactive Future Pharmaceutical Europe Index tracks the performance of the 15 largest European pharmaceutical companies by market capitalization, weighted according to their “Innovation Value”, thereby allocating more weight to companies investing a higher percentage of their total assets in research and development.
Master Data
ISIN: | DE000SLA5EB2 |
Bloomberg Ticker: | SOLFUPHA Index |
WKN: | SLA5EB |
Current Quotes
Last quote (23 Feb 2024): | 576.29 |
Day range: | 574.06 / 576.83 |
Change abs./rel.: | 2.48 / 0.43% |
Year range: | 533.32 / 622.83 |
Name | Number of shares |
---|---|
ARGENX SE | 0.187697 |
GENMAB A/S | 0.259584 |
SANOFI SA | 0.153612 |
UCB SA | 0.733456 |
ASTRAZENECA PLC | 0.495515 |
RECORDATI SPA | 0.686813 |
ROCHE HOLDING AG | 0.285868 |
BAYER AG | 0.301095 |
GSK PLC | 1.916861 |
LONZA GROUP AG | 0.029088 |
NOVARTIS AG | 0.33094 |
NOVO NORDISK A/S | 0.339098 |
IPSEN SA | 0.262222 |
SANDOZ GROUP AG | 0.066188 |
MERCK KGAA | 0.090014 |
SARTORIUS AG PREF | 0.042295 |